Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.

[1]  Declan T. Barry,et al.  Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. , 2016, Addiction.

[2]  Y. Olsen.  The CDC Guideline on Opioid Prescribing: Rising to the Challenge. , 2016, JAMA.

[3]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[4]  C. Green,et al.  Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. , 2016, Drug and alcohol dependence.

[5]  Alex Harocopos,et al.  Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City. , 2016, The International journal on drug policy.

[6]  D. Tauben,et al.  CDC guideline for prescribing opioids for chronic pain , 2016 .

[7]  L. Paulozzi,et al.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013. , 2015, Morbidity and mortality weekly report. Surveillance summaries.

[8]  K. Kampman,et al.  American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use , 2015, Journal of addiction medicine.

[9]  R. Manworren,et al.  CE: Nurses’ Role in Preventing Prescription Opioid Diversion , 2015, The American journal of nursing.

[10]  Christopher M. Jones,et al.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013 , 2015, MMWR. Morbidity and mortality weekly report.

[11]  M. Wolf,et al.  Improving patient knowledge and safe use of opioids: a randomized controlled trial. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[12]  Nathaniel Katz,et al.  Root cause analysis of prescription opioid overdoses. , 2015, Journal of opioid management.

[13]  T. Kwong,et al.  The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. , 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  N. Perrin,et al.  Costs of care for persons with opioid dependence in commercial integrated health systems , 2014, Addiction Science & Clinical Practice.

[15]  R. McHugh,et al.  Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. , 2014, Journal of substance abuse treatment.

[16]  Leonard J. Paulozzi,et al.  Vital Signs: Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines — United States, 2012 , 2014, MMWR. Morbidity and mortality weekly report.

[17]  Annesa Flentje,et al.  Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. , 2014, Drug and alcohol dependence.

[18]  Joshua M Sharfstein,et al.  Confronting the stigma of opioid use disorder--and its treatment. , 2014, JAMA.

[19]  F. Lynch,et al.  A qualitative study of the adoption of buprenorphine for opioid addiction treatment. , 2014, Journal of substance abuse treatment.

[20]  B. Martin,et al.  The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription , 2013, The Clinical journal of pain.

[21]  J. Davis,et al.  Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. , 2013, The journal of pain : official journal of the American Pain Society.

[22]  Hrishikesh Kale,et al.  Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics , 2013, Pharmacoepidemiology and drug safety.

[23]  K. Brady,et al.  Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. , 2013, The American journal on addictions.

[24]  S. Vosburg,et al.  Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone , 2013, PAIN®.

[25]  W. Ling,et al.  Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). , 2013, Journal of studies on alcohol and drugs.

[26]  Brian E. McCabe,et al.  Engagement, Retention, and Abstinence for Three Types of Opioid Users in Florida , 2013, Substance use & misuse.

[27]  W. Ling,et al.  A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users , 2013, Journal of addiction medicine.

[28]  R. Blondell,et al.  A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction , 2013, Journal of addictive diseases.

[29]  Matt Schiller,et al.  A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. , 2012, Pain medicine.

[30]  H. Surratt,et al.  Effect of abuse-deterrent formulation of OxyContin. , 2012, The New England journal of medicine.

[31]  M. Von Korff,et al.  Depression and Prescription Opioid Misuse Among Chronic Opioid Therapy Recipients With No History of Substance Abuse , 2012, The Annals of Family Medicine.

[32]  K. Brady,et al.  Characteristics and correlates of men and women with prescription opioid dependence. , 2011, Addictive behaviors.

[33]  S. Dobscha,et al.  Adherence to Clinical Guidelines for Opioid Therapy for Chronic Pain in Patients with Substance Use Disorder , 2011, Journal of General Internal Medicine.

[34]  Bradley C Martin,et al.  Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. , 2010, Drug and alcohol dependence.

[35]  N. Perrin,et al.  Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan. , 2010, Drug and alcohol dependence.

[36]  Johnny Saldaña,et al.  The Coding Manual for Qualitative Researchers , 2009 .

[37]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[38]  R. Chou,et al.  Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. , 2009, The journal of pain : official journal of the American Pain Society.

[39]  A. Stevens,et al.  Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatised identities. , 2008, Social science & medicine.

[40]  Lucy L Chen,et al.  Opioid tolerance and hyperalgesia. , 2007, The Medical clinics of North America.

[41]  Martin S. Angst,et al.  Opioid-induced Hyperalgesia: A Qualitative Systematic Review , 2006, Anesthesiology.

[42]  M. Sullivan,et al.  The missing 'P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. , 2014, General hospital psychiatry.

[43]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[44]  A. Winstock,et al.  "Should I stay or should I go?" Coming off methadone and buprenorphine treatment. , 2011, The International journal on drug policy.

[45]  A. Strauss,et al.  Excerpts from : The Discovery of Grounded Theory : Strategies for Qualitative Research , 2008 .

[46]  A. Strauss,et al.  Grounded theory methodology: An overview. , 1994 .